Publication | Open Access

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

Breast OncologyMedicineCancer ManagementPharmacologyClinical TrialsGynecologyPlacebo-controlled TrialBreast CancerPharmacotherapyMenopauseMenopause Hormone TherapyOncologyWomen's HealthHigh-risk Postmenopausal Women